TrialDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft2015

[Change of therapy from ranibizumab to aflibercept for recurrent or persistent exudative age-related macular degeneration].

M Ziegler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.